| TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
STAT2 |
STAT2: Signal transducer and activator of transcription 2 |
0.78 |
Evidence |
|
| TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
TEK |
TEK, TIE2: Angiopoietin-1 receptor precursor |
0.78 |
Evidence |
|
| GNAL |
GNAL: Guanine nucleotide-binding protein G(olf) subunit alpha |
RGS4 |
RGS4: Regulator of G-protein signaling 4 |
0.78 |
Evidence |
|
| TGFBR2 |
TGFBR2: TGF-beta receptor type-2 precursor |
GDF15 |
GDF15, MIC1, PDF, PLAB, PTGFB: Growth/differentiation factor 15 precursor |
0.78 |
Evidence |
|
| SERPINF1 |
SERPINF1, PEDF: Pigment epithelium-derived factor precursor |
ST14 |
ST14, PRSS14, SNC19, TADG15: Suppressor of tumorigenicity protein 14 |
0.78 |
Evidence |
|
| KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
0.78 |
Evidence |
|
| CTNNB1 |
CTNNB1, CTNNB, OK/SW-cl.35, PRO2286: Catenin beta-1 |
CDH13 |
CDH13, CDHH: Cadherin-13 precursor |
0.78 |
Evidence |
|
| TRHR |
TRHR: Thyrotropin-releasing hormone receptor |
CCL14 |
CCL14, NCC2, SCYA14: Small-inducible cytokine A14 precursor |
0.78 |
Evidence |
|
| SSTR3 |
SSTR3: Somatostatin receptor type 3 |
CORT |
CORT, UNQ307/PRO350: Cortistatin precursor [Contains: Cortistatin-29; Cortistati |
0.78 |
Evidence |
O
|
| SSTR3 |
SSTR3: Somatostatin receptor type 3 |
CCL11 |
CCL11, SCYA11: Eotaxin precursor |
0.78 |
Evidence |
|
| MC4R |
MC4R: Melanocortin receptor 4 |
CCL8 |
CCL8, MCP2, SCYA10, SCYA8: Small-inducible cytokine A8 precursor |
0.78 |
Evidence |
|
| MC4R |
MC4R: Melanocortin receptor 4 |
CCL11 |
CCL11, SCYA11: Eotaxin precursor |
0.78 |
Evidence |
|
| MC4R |
MC4R: Melanocortin receptor 4 |
XCL1 |
XCL1, LTN, SCYC1: Lymphotactin precursor |
0.78 |
Evidence |
|
| AGTR1 |
AGTR1, AGTR1A, AGTR1B, AT2R1, AT2R1B: Type-1 angiotensin II receptor |
CXCL9 |
CXCL9, CMK, MIG, SCYB9: Small-inducible cytokine B9 precursor |
0.78 |
Evidence |
|
| GNA11 |
GNA11, GA11: Guanine nucleotide-binding protein subunit alpha-11 |
RGS4 |
RGS4: Regulator of G-protein signaling 4 |
0.78 |
Evidence |
|
| EPHA2 |
EPHA2, ECK: Ephrin type-A receptor 2 precursor |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
0.78 |
Evidence |
|
| HTR2C |
HTR2C, HTR1C: 5-hydroxytryptamine receptor 2C |
CXCL9 |
CXCL9, CMK, MIG, SCYB9: Small-inducible cytokine B9 precursor |
0.78 |
Evidence |
|
| F2R |
F2R, CF2R, PAR1, TR: Proteinase-activated receptor 1 precursor |
CXCL9 |
CXCL9, CMK, MIG, SCYB9: Small-inducible cytokine B9 precursor |
0.78 |
Evidence |
|
| F2R |
F2R, CF2R, PAR1, TR: Proteinase-activated receptor 1 precursor |
CCL11 |
CCL11, SCYA11: Eotaxin precursor |
0.78 |
Evidence |
|
| FPRL1 |
FPRL1, FPR2, FPRH1, LXA4R: FMLP-related receptor I |
CXCL5 |
CXCL5, ENA78, SCYB5: Small-inducible cytokine B5 precursor |
0.78 |
Evidence |
|
| IL8RB |
IL8RB, CXCR2: High affinity interleukin-8 receptor B |
XCL1 |
XCL1, LTN, SCYC1: Lymphotactin precursor |
0.78 |
Evidence |
|
| IL8RB |
IL8RB, CXCR2: High affinity interleukin-8 receptor B |
CXCL5 |
CXCL5, ENA78, SCYB5: Small-inducible cytokine B5 precursor |
0.78 |
Evidence |
O
|
| FGFR4 |
FGFR4, JTK2, TKF: Fibroblast growth factor receptor 4 precursor |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
0.78 |
Evidence |
|
| FGFR4 |
FGFR4, JTK2, TKF: Fibroblast growth factor receptor 4 precursor |
SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
0.78 |
Evidence |
|
| CCL1 |
CCL1, SCYA1: Small-inducible cytokine A1 precursor |
F2RL3 |
F2RL3, PAR4: Proteinase-activated receptor 4 precursor |
0.78 |
Evidence |
|